Skip to main content
. Author manuscript; available in PMC: 2020 Jan 1.
Published in final edited form as: Gastroenterology. 2018 Sep 19;156(2):311–324. doi: 10.1053/j.gastro.2018.07.057

Figure 3. High-throughput Screen for Anti-HBV Compounds.

Figure 3.

A high-throughput screen for compounds that inhibit HBV involves culture of HBV-susceptible hepatocytes, followed by infection with HBV and addition of compound library. Compounds found to block HBV entry or replication in this assay can be validated in additional assays and for their effects on cell viability.